Exclusion of immunocompromised patients and patients with hematological malignancies resulted in significant differences of TGF-β levels between IC (true) and bacteremic patients for time intervals (−4; −2), (−1; 2) and (3; 7), with significantly higher values in candidemic patients. The gene discussed is TGFB1; the disease is hematologic disorder.